Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -3.14% is 18% above its 5-year average of -3.83%, around the middle of its 5-year range (-45.10%–15.30%).
6718.26% below its 12-month average of -0.05%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.97%.
EBITDA MARGIN
-3.14%
EBITDA MARGIN AVG TTM
-0.05%
EBITDA MARGIN AVG 3Y
-0.02%
EBITDA MARGIN AVG 5Y
-3.83%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6718.26%
CURRENT VS 3Y AVG
-13007.88%
CURRENT VS 5Y AVG
+18.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Oscar Health, Inc.
Market Cap
$8.33B
EBITDA Margin
-3.14%
TTM Avg
-0.05%
3Y Avg
-0.02%
5Y Avg
-3.83%
Market Cap
$9.99B
EBITDA Margin
20.41%
TTM Avg
18.54%
3Y Avg
20.94%
5Y Avg
21.85%
Market Cap
$6.59B
EBITDA Margin
15.93%
TTM Avg
16.80%
3Y Avg
17.55%
5Y Avg
18.41%
Market Cap
$10.13B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
Market Cap
$10.14B
EBITDA Margin
10.47%
TTM Avg
10.43%
3Y Avg
10.38%
5Y Avg
10.85%
Market Cap
$6.24B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$10.48B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $8.33B | -3.14% | -0.05% | -0.02% | -3.83% |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | 8.11% | 8.11% | 8.28% | 8.19% |
| Insulet Corp. (PODD)vs › | $9.74B | 21.67% | 20.24% | 16.36% | 15.66% |
| Globus Medical, Inc. (GMED)vs › | $9.99B | 20.41% | 18.54% | 20.94% | 21.85% |
| Chemed Corporation (CHE)vs › | $6.59B | 15.93% | 16.80% | 17.55% | 18.41% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.13B | 18.42% | 17.41% | 19.12% | 20.05% |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 10.47% | 10.43% | 10.38% | 10.85% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | 6.82% | 6.08% | -0.44% | -8.67% |
| Molina Healthcare, Inc. (MOH)vs › | $10.48B | 2.15% | 3.41% | 4.20% | 4.49% |
| Align Technology, Inc. (ALGN)vs › | $10.57B | 19.75% | 19.29% | 19.87% | 21.06% |
Gross Margin
14.4%
EBITDA Margin
-3.1%
Operating Margin
4.1%
Net Margin
3.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 7.97% |
| 2026-03-31 | 15.30% |
| 2025-12-31 | -11.62% |
| 2025-09-30 | -4.08% |
| 2025-06-30 | -7.80% |
| 2025-03-31 | 9.97% |
| 2024-12-31 | -5.79% |
| 2024-09-30 | -1.85% |
| 2024-06-30 | 3.09% |
| 2024-03-31 | 8.69% |
| 2023-12-31 | -9.98% |
| 2023-09-30 | -3.86% |
| 2023-06-30 | -0.36% |
| 2023-03-31 | -2.22% |
| 2022-12-31 | -21.54% |
| 2022-09-30 | -18.76% |
| 2022-06-30 | -10.22% |
| 2022-03-31 | -7.12% |
| 2021-12-31 | -37.36% |
| 2021-09-30 | -45.10% |
| 2021-06-30 | -12.58% |
| 2021-03-31 | -21.74% |
| 2020-12-31 | -99.69% |
| 2020-09-30 | -57.91% |
| 2020-06-30 | -25.30% |
| 2020-03-31 | -75.86% |
